Diagnostic Value of Image-Guided Percutaneous Biopsy of Omental and Peritoneal Lesions
DOI:
https://doi.org/10.3126/njr.v15i2.95808Keywords:
Communicable Diseases, Cytology, Neoplasms, PeritonitisAbstract
Introduction: The peritoneum and omentum are frequently involved in both malignant and inflammatory conditions, many of which demonstrate overlapping imaging features. Image guided percutaneous biopsy has emerged as a minimally invasive alternative to surgical sampling for histopathological confirmation.
Methods: A prospective observational study was conducted in the Department of Radiology at Nobel Medical College Teaching Hospital, Biratnagar, Nepal. Adults (≥18 years) undergoing image-guided percutaneous biopsy of peritoneal or omental lesions with available histopathology were included. Forty-three patients were enrolled consecutively. Procedures were performed under ultrasound or CT guidance using core needle biopsy or fine-needle aspiration cytology. Data were analyzed in SPSS v27 and expressed as mean ± standard deviation and frequency.
Results: The mean age of participants was 52.40 ± 13.20 years, with females comprising 58.1% of the study population. The average lesion size was 4.20 ± 1.60 cm. Peritoneal involvement was observed in 58.1% of cases, while 41.9% involved the omentum. Computed Tomography guidance was utilized in 72.1% of procedures, and core biopsy was performed in 86.0%. Technical success and diagnostic yield were both 97.7%. Malignancy was the most common diagnosis (67.4%), followed by tuberculous peritonitis (23.3%). Minor complications occurred in 7.0% of cases, with no major adverse events reported.
Conclusions: Image-guided percutaneous biopsy of omental and peritoneal lesions is a safe and reliable diagnostic method with high yield. It should be considered a first-line approach for tissue diagnosis, particularly in settings with a high burden of malignancy and infectious diseases.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nepalese Journal of Radiology

This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.